ClearPoint Neuro, Inc. beat EPS estimates 0% of the time across 3 reported quarters (0 beats, 3 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.29 | $-0.38 | -31.0% | Miss |
| Q12026 FY2026 | $-0.28 | $-0.32 | -14.3% | Miss |
| Q42025 FY2025 | $-0.22 | $-0.27 | -22.7% | Miss |
Back to CLPT overview · CLPT holders · CLPT KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.